Stocks rose on Monday, but analysts expect a bumpy ride for share prices while experts assess whether existing vaccines will be effective against the new variant.
Posted inBusiness
With Omicron, Stock Analysts Expecting More Uncertainty
Stocks rose on Monday, but analysts expect a bumpy ride for share prices while experts assess whether existing vaccines will be effective against the new variant.